Search

Your search keyword '"Tominaga, Keiichi"' showing total 13 results
Start Over Author "Tominaga, Keiichi" Publisher wiley
13 results on '"Tominaga, Keiichi"'

2. A case in which the tip of a plastic stent placed to prevent recurrence of walled‐off necrosis penetrated the bile duct and formed a stent–stone complex

Author

Sakuma, Fumi, primary, Irisawa, Atsushi, additional, Noguchi, Satoaki, additional, Abe, Yoko, additional, Hoshi, Koki, additional, Yamamiya, Akira, additional, Nagashima, Kazunori, additional, Kashima, Ken, additional, Kunogi, Yasuhito, additional, Fukushi, Koh, additional, Inaba, Kohei, additional, Oike, Ken, additional, Furuki, Saori, additional, Tominaga, Keiichi, additional, and Goda, Kenichi, additional

Published
2023
Full Text
View/download PDF

3. Diagnosing chronic pancreatitis by endoscopic ultrasound assessing the association between ultrasound and pathological findings: A narrative review

Author

Yamamiya, Akira, primary, Irisawa, Atsushi, additional, Abe, Yoko, additional, Arisaka, Takahiro, additional, Ohnishi, Toshihiko, additional, Hoshi, Koki, additional, Suzuki, Tsunehiro, additional, Nagashima, Kazunori, additional, Kashima, Ken, additional, Kunogi, Yasuhito, additional, Sakuma, Fumi, additional, Fukushi, Koh, additional, Ishikawa, Manabu, additional, Mizuguchi, Nasuka, additional, Yamaguchi, Shintaro, additional, Tominaga, Keiichi, additional, and Goda, Kenichi, additional

Published
2022
Full Text
View/download PDF

4. A case of obstructive jaundice caused by metastasis of breast cancer to the intra/extrahepatic bile duct

Author

Suzuki, Yuka, primary, Hoshi, Koki, additional, Tominaga, Keiichi, additional, Inaba, Yasunori, additional, Yoshinaga, Tomonori, additional, Kojimahara, Shunsuke, additional, Maki, Ryuichi, additional, Nemoto, Rena, additional, Tetsuka, Yugo, additional, Kawata, Yosuke, additional, Yamamiya, Akira, additional, Sugaya, Takeshi, additional, Iso, Yukihiro, additional, Takada‐Owada, Atsuko, additional, Ishida, Kazuyuki, additional, Goda, Kenichi, additional, and Irisawa, Atsushi, additional

Published
2022
Full Text
View/download PDF

5. Size reduction of gastric fundic gland polyposis by de‐escalation of acid‐suppressive therapy

Author

Kanamori, Akira, primary, Tominaga, Keiichi, additional, Masuyama, Hironori, additional, Ishikawa, Mutsumi, additional, Masuyama, Satoshi, additional, Kondo, Masayuki, additional, Kanazawa, Mimari, additional, Tanaka, Takanao, additional, Yamaura, Masamichi, additional, Abe, Keiichiro, additional, Watanabe, Shoko, additional, Yamamiya, Akira, additional, Abe, Yoko, additional, Goda, Kenichi, additional, and Irisawa, Atsushi, additional

Published
2022
Full Text
View/download PDF

6. Measuring optimal ultrasound speed using endoscopic ultrasound in patients with chronic pancreatitis, including early stage

Author

Minaguchi, Takahito, primary, Yamamiya, Akira, additional, Tominaga, Keiichi, additional, Kashima, Ken, additional, Kunogi, Yasuhito, additional, Sakuma, Fumi, additional, Fukushi, Koh, additional, Nagashima, Kazunori, additional, Izawa, Naoya, additional, Yamabe, Akane, additional, Hoshi, Koki, additional, Iijima, Makoto, additional, Goda, Kenichi, additional, Haruyama, Yasuo, additional, and Irisawa, Atsushi, additional

Published
2022
Full Text
View/download PDF

8. Significance of measurement of serum trough level and anti-drug antibody of adalimumab as personalised pharmacokinetics in patients with Crohn's disease: a subanalysis of the DIAMOND trial

Author

Nakase, H., Motoya, S., Matsumoto, T., Watanabe, K., Hisamatsu, T., Yoshimura, N., Ishida, T., Kato, S., Nakagawa, T., Esaki, M., Nagahori, M., Matsui, T., Naito, Y., Kanai, T., Suzuki, Y., Nojima, M., Watanabe, M., Hibi, T., Andoh, Akira, Ashida, Toshifumi, Endo, Katsuya, Endo, Yutaka, Esaki, Motohiro, Fujita, Hiroshi, Fujiya, Mikihiro, Haruma, Ken, Hibi, Toshifumi, Hiraoka, Sakiko, Hirata, Ichiro, Hisamatsu, Tadakazu, Honda, Yutaka, Iijima, Hideki, Iizuka, Bunei, Ikeya, Kentaro, Inoue, Takuya, Inoue, Shuji, Ishida, Tetsuya, Ishiguro, Yo, Ishihara, Shunji, Ito, Hiroaki, Iwakiri, Ryuichi, Kagaya, Takashi, Kanai, Takanori, Kashida, Hiroshi, Kato, Shingo, Kato, Jun, Katsurada, Takehiko, Kinjyo, Fukunori, Kobayashi, Kiyonori, Kodama, Mayumi, Kunisaki, Reiko, Kurahara, Koichi, Kurokami, Takafumi, Kyouwon, Lee, Matsuda, Koichiro, Matsueda, Kazuhiro, Matsui, Toshiyuki, Matsumoto, Takayuki, Mitsuyama, Keiichi, Mizokami, Yuji, Motoya, Satoshi, Naito, Yuji, Nakagawa, Tomoo, Nakamura, Shiro, Nakase, Hiroshi, Nojima, Masanori, Nomura, Masafumi, Ogawa, Atsuhiro, Okazaki, Kazuichi, Otsuka, Kazuaki, Sakuraba, Hirotake, Saruta, Masayuki, Sasaki, Makoto, Shirai, Takayuki, Suga, Tomoaki, Sugimura, Kazuhito, Sugiyama, Toshiro, Suzuki, Yasuo, Takeshima, Fuminao, Tamaki, Hiroyuki, Tanaka, Shinji, Tanida, Satoshi, Tominaga, Keiichi, Tomizawa, Taku, Watanabe, Kenji, Watanabe, Mamoru, Yamamoto, Shojiro, Yamashita, Masaki, Yoshida, Atsushi, and Yoshimura, Naoki

Subjects
musculoskeletal diseases, medicine.medical_specialty, Combination therapy, Gastroenterology, law.invention, 03 medical and health sciences, 0302 clinical medicine, Pharmacotherapy, Randomized controlled trial, Pharmacokinetics, law, Internal medicine, medicine, Adalimumab, Pharmacology (medical), skin and connective tissue diseases, Crohn's disease, Hepatology, biology, business.industry, medicine.disease, Surgery, Personalised Adalimumab Pharmacokinetics, 030220 oncology & carcinogenesis, biology.protein, Trough level, Original Article, 030211 gastroenterology & hepatology, Antibody, business, medicine.drug
Abstract

Summary Background Significance of monitoring adalimumab trough levels and anti‐adalimumab antibodies (AAA) for disease outcome in Crohn's disease (CD) patients remained unclear. Aim To evaluate the association of adalimumab trough levels and AAA at week 26 with clinical remission at week 52, the effect of azathiopurine on AAA and factors influencing trough levels in CD patients in the DIAMOND trial. Methods We performed this study using adalimumab trough levels, AAA at week 26 and 6‐thioguanine nucleotide (TGN) in red blood cells at week 12. A multiple regression model and receiver operating analysis was performed to identify factors influencing adalimumab trough levels and AAA, and adalimumab thresholds for predicting disease activity. Results There was a significant difference of adalimumab trough level at week 26 between patients with disease remission and without at week 52 (7.7 ± 3.3 μg/mL vs 5.4 ± 4.3 μg/mL: P 222.5 p mol/8 ×108 RBCs yielded sensitivity (100%) and specificity (60.6%) for AAA negativity. Conclusion Adalimumab trough levels and AAA occurrence were significantly associated with clinical remission. Higher 6TGN affected AAA negativity. The combination therapy is beneficial in some relevant aspects for CD patients. (UMIN Registration No. 000005146)

Published
2017
Full Text
View/download PDF

12. IPMN PENETRATION OF THE STOMACH

Author

Nakano, Masakazu, primary, Tominaga, Keiichi, additional, Watanabe, Hidetaka, additional, Kanke, Kazunari, additional, Tamano, Masaya, additional, and Hiraishi, Hideyuki, additional

Published
2010
Full Text
View/download PDF

13. Analysis of K-ras mutations and expression of cyclooxygenase-2 and gastrin protein in laterally spreading tumors

Author

MUKAWA, KENICHIROH, primary, FUJII, SHIGEHIKO, additional, TAKEDA, JUN, additional, KITAJIMA, KAZUAKI, additional, TOMINAGA, KEIICHI, additional, CHIBANA, YOKO, additional, FUJITA, MIKIO, additional, ICHIKAWA, KAZUHITO, additional, TOMITA, SHIGEKI, additional, ONO, YUKO, additional, IMURA, JOHJI, additional, KAWAMATA, HITOSHI, additional, CHIBA, TSUTOMU, additional, HIRAISHI, HIDEYUKI, additional, TERANO, AKIRA, additional, and FUJIMORI, TAKAHIRO, additional

Published
2005
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results